Posttranslational modifications of proteins are key features in the identification of CSF biomarkers of multiple sclerosis

Table 1 Demographic and clinical features of the patients included in the study: CSF samples

	Disease	Number of patients	Age (Mean ± SD)	Gender
Discovery	RRMS	69	36.9 ± 10.6	25M; 44F
	INF	27	46.4 ± 15.7	10M; 17F
	N-INF	42	45.3 ± 11.2	14M; 28F
Validation	RRMS	68	36.8 ± 9.9	18M; 50F
	INF	53	46.6 ± 15.6	20M; 33F
	N-INF	74	51.9 ± 11.9	29M; 45F

M male, F female, RRMS Relapse–remitting multiple sclerosis, INF other inflammatory diseases of the CNS, N-INF non-inflammatory diseases of the CNS

ISSN: 1742-2094